Eli Lilly earnings topped Q4 views with 2025 guidance above consensus, even though Zepbound and Mounjaro slightly missed. Eli Lilly stock rose.
The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...
With shares under $1, Nikola (NASDAQ: NKLA) is risking bankruptcy, underscoring the larger difficulties smaller EV firms like Lucid (NASDAQ: LCID) and Rivian (NASDAQ: RIVN). While conventional ...
The stock market showed resilience after Monday's DeepSeek-spurred sell-off in AI hardware stocks. Apple, Tesla, Microsoft led big earnings.
Looking for the latest stock opportunities in February 2025? We have you covered. Click to read our top stock picks to ...